Literature DB >> 16867223

In vivo spectral fluorescence imaging of submillimeter peritoneal cancer implants using a lectin-targeted optical agent.

Yukihiro Hama1, Yasuteru Urano, Yoshinori Koyama, Mako Kamiya, Marcelino Bernardo, Ronald S Paik, Murali C Krishna, Peter L Choyke, Hisataka Kobayashi.   

Abstract

Intraperitoneal metastases commonly recur after surgery because small tumor foci escape detection within the complex anatomy of the peritoneal cavity and mesentery. Accurate localization of peritoneal implants during surgery could improve the resection of ovarian cancer and other malignancies, but few practical techniques to enhance detectability are currently available. Here, we describe a targeted molecular imaging method that employs fluorescently labeled avidin to detect submillimeter peritoneal implants of ovarian cancer in mice. After binding to surface lectins on the tumor, fluorescein-conjugated avidin enabled the spectral fluorescence imaging of disseminated peritoneal implants. High spatial resolution and high tumor-to-background ratio allowed the visualization of implants as small as 0.3 mm (with 100% sensitivity and specificity; n = 150) and the identification of even smaller lesions ex vivo. These results suggest that targeted molecular imaging with a fluorescence-labeled lectin-ligand system is a promising technique for the detection of disseminated submillimeter foci of cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16867223      PMCID: PMC1601930          DOI: 10.1593/neo.06268

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  20 in total

Review 1.  Optical-based molecular imaging: contrast agents and potential medical applications.

Authors:  Christoph Bremer; Vasilis Ntziachristos; Ralph Weissleder
Journal:  Eur Radiol       Date:  2002-08-13       Impact factor: 5.315

2.  Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

Authors:  Deborah K Armstrong; Brian Bundy; Lari Wenzel; Helen Q Huang; Rebecca Baergen; Shashikant Lele; Larry J Copeland; Joan L Walker; Robert A Burger
Journal:  N Engl J Med       Date:  2006-01-05       Impact factor: 91.245

Review 3.  Lectins in cancer cells.

Authors:  R Lotan; A Raz
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

4.  Establishment and characterization of a human ovarian serous cystadenocarcinoma cell line that produces the tumor markers CA-125 and tissue polypeptide antigen.

Authors:  S Imai; Y Kiyozuka; H Maeda; T Noda; H L Hosick
Journal:  Oncology       Date:  1990       Impact factor: 2.935

5.  Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.

Authors:  Robert E Bristow; Rafael S Tomacruz; Deborah K Armstrong; Edward L Trimble; F J Montz
Journal:  J Clin Oncol       Date:  2002-03-01       Impact factor: 44.544

Review 6.  Endogenous tumor lectins: overview and perspectives.

Authors:  H J Gabius; R Engelhardt; F Cramer
Journal:  Anticancer Res       Date:  1986 Jul-Aug       Impact factor: 2.480

Review 7.  Cancer statistics, 2004.

Authors:  Ahmedin Jemal; Ram C Tiwari; Taylor Murray; Asma Ghafoor; Alicia Samuels; Elizabeth Ward; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

Review 8.  The present and future role of photodynamic therapy in cancer treatment.

Authors:  Stanley B Brown; Elizabeth A Brown; Ian Walker
Journal:  Lancet Oncol       Date:  2004-08       Impact factor: 41.316

9.  Immunogenicity of biotinylated hapten-avidin complexes.

Authors:  D Scott; D E Nitecki; H Kindler; J W Goodman
Journal:  Mol Immunol       Date:  1984-11       Impact factor: 4.407

10.  Predictability of the survival of patients with advanced ovarian cancer.

Authors:  J C van Houwelingen; W W ten Bokkel Huinink; M E van der Burg; A T van Oosterom; J P Neijt
Journal:  J Clin Oncol       Date:  1989-06       Impact factor: 44.544

View more
  17 in total

Review 1.  Intraoperative imaging in ovarian cancer: fact or fiction?

Authors:  Lucia M A Crane; Marleen van Oosten; Rick G Pleijhuis; Arash Motekallemi; Sean C Dowdy; William A Cliby; Ate G J van der Zee; Gooitzen M van Dam
Journal:  Mol Imaging       Date:  2011-04-26       Impact factor: 4.488

2.  Highly Specific and Sensitive Fluorescent Nanoprobes for Image-Guided Resection of Sub-Millimeter Peritoneal Tumors.

Authors:  Aaron H Colby; Samantha M Berry; Ann M Moran; Kristine Amber Pasion; Rong Liu; Yolonda L Colson; Nelson Ruiz-Opazo; Mark W Grinstaff; Victoria L M Herrera
Journal:  ACS Nano       Date:  2017-02-01       Impact factor: 15.881

3.  The use of fluorescent proteins for developing cancer-specific target imaging probes.

Authors:  Thomas E McCann; Nobuyuki Kosaka; Peter L Choyke; Hisataka Kobayashi
Journal:  Methods Mol Biol       Date:  2012

4.  Dual-labeled pertuzumab for multimodality image-guided ovarian tumor resection.

Authors:  Hye Jin Lee; Emily B Ehlerding; Dawei Jiang; Todd E Barnhart; Tianye Cao; Weijun Wei; Carolina A Ferreira; Peng Huang; Jonathan W Engle; Weibo Cai
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

5.  An enzymatically activated fluorescence probe for targeted tumor imaging.

Authors:  Mako Kamiya; Hisataka Kobayashi; Yukihiro Hama; Yoshinori Koyama; Marcelino Bernardo; Tetsuo Nagano; Peter L Choyke; Yasuteru Urano
Journal:  J Am Chem Soc       Date:  2007-03-13       Impact factor: 15.419

6.  A comparison of the emission efficiency of four common green fluorescence dyes after internalization into cancer cells.

Authors:  Yukihiro Hama; Yasuteru Urano; Yoshinori Koyama; Marcelino Bernardo; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2006 Nov-Dec       Impact factor: 4.774

Review 7.  New strategies for fluorescent probe design in medical diagnostic imaging.

Authors:  Hisataka Kobayashi; Mikako Ogawa; Raphael Alford; Peter L Choyke; Yasuteru Urano
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

8.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

9.  Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin-conjugated fluorophore.

Authors:  Andrew J Gunn; Yukihiro Hama; Yoshinori Koyama; Elise C Kohn; Peter L Choyke; Hisataka Kobayashi
Journal:  Cancer Sci       Date:  2007-09-02       Impact factor: 6.716

10.  Galactosyl human serum albumin-NMP1 conjugate: a near infrared (NIR)-activatable fluorescence imaging agent to detect peritoneal ovarian cancer metastases.

Authors:  Vinita M Alexander; Kohei Sano; Zhanqian Yu; Takahito Nakajima; Peter L Choyke; Marcin Ptaszek; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2012-07-30       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.